DMF Medical Incorporated was founded with the sole purpose of
making anesthesisa safer.
The company’s lead product – memsorb - will be the next generation in CO2 removal for anesthesia circuits. Our patented technology uses membrane separation technology to remove CO2, rather than a traditional chemical reaction.
This device will provide a game changing solution to the known dilemma associated with current chemical CO2 absorbers, and aims to provide safer anesthesia, protect the environment and save money.
memsorb is currently under development, and is not yet commercially available.
Please contact us for further information at firstname.lastname@example.org